Free. Unsubscribe any time.
Revolution Medicines, Inc. (RVMD)
Revolution Medicines, Inc. filed 66 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 10 reporting owners, covering 160 transactions and 1,262,542 shares. 66 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-15, came 1 day after the one before it (2026-09-14) and reports 12 transactions against 7 in the filing before it.
- The sales it reports total 92,531 shares, 77,083 more than the 15,448 in the filing before it.
- Its 66 plan statements rank 70th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 66 filings on file run from 2025-01-22 to 2026-09-15, and state 16 plan adoption dates, from 2023-05-31 to 2026-06-12.
Trades in Revolution Medicines, Inc. 160
- Cislini Jeff — 2025-01-21 · S · 2,406 shares
- Anders Jack — 2025-03-17 · S · 1,864 shares
- Cislini Jeff — 2025-03-17 · S · 1,458 shares
- GOLDSMITH MARK A — 2025-03-17 · S · 11,738 shares
- Horn Margaret A — 2025-03-17 · S · 3,058 shares
- Kelsey Stephen Michael — 2025-03-17 · S · 3,294 shares
- Cislini Jeff — 2025-03-20 · S · 2,041 shares
- Anders Jack — 2025-06-16 · S · 2,170 shares
- Cislini Jeff — 2025-06-16 · S · 1,878 shares
- GOLDSMITH MARK A — 2025-06-16 · S · 13,496 shares
- Horn Margaret A — 2025-06-16 · S · 3,510 shares
- Horn Margaret A — 2025-06-16 · S · 3,575 shares
Adoption dates in Revolution Medicines, Inc. 16
- 2023-05-31 — stated in 29 filings
- 2024-03-20 — stated in 2 filings
- 2024-12-16 — stated in 4 filings
- 2024-12-23 — stated in 2 filings
- 2025-02-28 — stated in 2 filings
- 2025-03-07 — stated in 1 filing
- 2025-03-13 — stated in 5 filings
- 2025-11-17 — stated in 1 filing
- 2025-12-24 — stated in 3 filings
- 2026-03-12 — stated in 2 filings
- 2026-03-24 — stated in 1 filing
- 2026-03-30 — stated in 1 filing
Results prints in Revolution Medicines, Inc. 7
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-02-25
- 2026-05-06
- 2026-08-05
Trades before a print in Revolution Medicines, Inc. 0
- 9 days before the 2026-05-06 print — 2026-04-27 · S · Mancini Anthony · 1,671 shares
- 9 days before the 2026-05-06 print — 2026-04-27 · S · Mancini Anthony · 1,049 shares
- 9 days before the 2026-05-06 print — 2026-04-27 · S · Mancini Anthony · 400 shares
- 19 days before the 2025-11-05 print — 2025-10-17 · S · Cislini Jeff · 12,000 shares
- 19 days before the 2025-11-05 print — 2025-10-17 · S · GOLDSMITH MARK A · 10,000 shares
- 20 days before the 2025-11-05 print — 2025-10-16 · S · GOLDSMITH MARK A · 10,000 shares
- 21 days before the 2026-05-06 print — 2026-04-15 · S · GOLDSMITH MARK A · 120,000 shares
- 23 days before the 2025-11-05 print — 2025-10-13 · S · Kelsey Stephen Michael · 25,000 shares
- 35 days before the 2026-02-25 print — 2026-01-21 · S · Cislini Jeff · 908 shares
- 36 days before the 2025-02-26 print — 2025-01-21 · S · Cislini Jeff · 2,406 shares
- 37 days before the 2026-08-05 print — 2026-06-29 · S · Patel Sushil · 300 shares
- 37 days before the 2026-08-05 print — 2026-06-29 · S · Patel Sushil · 900 shares
Interval to Revolution Medicines, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 3within 10 days
- 9shortest, days
- 51no later print
- Mancini Anthony 2026-04-27 · S · 9 days before the 2026-05-06 print · See Remarks
- Mancini Anthony 2026-04-27 · S · 9 days before the 2026-05-06 print · See Remarks
- Mancini Anthony 2026-04-27 · S · 9 days before the 2026-05-06 print · See Remarks
Adoption dates Revolution Medicines, Inc. states
- 2023-05-31 in 29 filings
- 2024-03-20 in 2 filings
- 2024-12-16 in 4 filings
- 2024-12-23 in 2 filings
- 2025-02-28 in 2 filings
- 2025-03-07 in 1 filing
- 2025-03-13 in 5 filings
- 2025-11-17 in 1 filing
- 2025-12-24 in 3 filings
- 2026-03-12 in 2 filings
- 2026-03-24 in 1 filing
- 2026-03-30 in 1 filing
- 2026-05-22 in 1 filing
- 2026-06-01 in 2 filings
- 2026-06-11 in 1 filing
- 2026-06-12 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Lorence Kim Revocable Trust on June 1, 2026”
Reported results dates on file
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-05
- 2026-02-25
- 2026-05-06
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.